Leadership
& Team
Revolutionizing
Cell & Gene Therapy
Through Innovation
Leadership
& Team
At CCS, our leadership team is composed of industry experts with deep expertise in cell and gene therapy academic partnerships, stem cell therapies, immune cell therapies, autologous/allogeneic cell therapies, and GMP manufacturing. With backgrounds in pharmaceutical operations, development, cell therapy manufacturing, quality, and regulatory affairs, our leaders bring decades of experience in scalable cell therapy solutions, process validation, regulatory compliance and technology transfer.
From overseeing multi-site GMP manufacturing to advancing technology transfer strategies, our experts work collaboratively to discover, develop, and meet the needs of academic researchers, emerging biotech firms, and global pharmaceutical companies. We are committed to transforming advanced cell engineering into life-changing therapies, ensuring that every project benefits from our precision, scalability, and quality-driven approach.
Thus, at CCS, our people are our greatest asset — driving next-generation solutions that advance the development and delivery of cell and gene therapies.
Our Leadership Team:
Jo Anne Valentino, MS
Senior Vice President, CCS
Rawlinson Isaac, MPA
Vice President Cell Sourcing & Clinical Apheresis
Manlio Narici, MBA
Executive Director, Business Operations
Ayanna Bryan, PhD
Senior Director & Site Head, CCS NY & Senior Program Director NCBP
Omar F. Baez
Senior Director GMP Cell & Gene Manufacturing and Site Head
Rubina Pal, PhD, SCYM (ASCPi)
Senior Director, Process and Analytical Development, Site Head
Joseph Dwyer
Senior Director, Head of Quality Control
Betsy W. Jett
Senior Vice President, Quality/Regulatory Affairs
Andi Baggarley, MSHA MT(ASCP)
Director of Project Management
Dr. Patricia Shi, MD
VP at NYBC & Medical Director of CCS, Cellular Therapy Collections, Cellular Therapy Processing & NCBP
Christian Rouldan
Senior Director of Business Development